PHILADELPHIA (July 27, 2023)—Temple Health and Fox Chase Cancer Center are pleased to announce the hiring of Sukhmani K. Padda, MD, as Professor and Vice Chair of Medical Oncology at the Fox Chase Cancer Center at Temple University Hospital.
Padda is a phase 1 and thoracic medical oncologist. Her research focuses on targeted therapeutics in genomic subsets of non-small cell lung cancer, as well as rare thoracic tumors, including neuroendocrine tumors and thymic malignancies. She is active in the National Clinical Trials Network and leads national studies investigating novel therapeutics in lung cancer.
Padda comes to Temple Health and Fox Chase from Cedars-Sinai Medical Center in Los Angeles, where she was Director of Thoracic Medical Oncology and an Associate Professor of medicine. Prior to that, Padda spent several years at Stanford University as an Assistant Professor of medicine and Phase 1 Clinical Research Group Leader.
Padda completed a six-year combined BS/MD program at the University of Akron and Northeast Ohio Medical University. She completed her fellowship in medical oncology and hematology, as well as her residency in internal medicine, at Stanford University.
She is a member of the American Society of Clinical Oncology, the International Association for the Study of Lung Cancer, the North American Neuroendocrine Tumor Society, and the International Thymic Malignancy Interest Group. Over the course of her career, Padda has earned multiple honors, including the Department of Medicine Teaching Award from Stanford University and the Stanford Cancer Institute Cancer Innovation Award.
She is a reviewer for various journals, including the Journal of Thoracic Oncology, Lancet Oncology, Lung Cancer, and the Journal of Clinical Oncology. She has also published over 50 peer-reviewed journal articles as well as numerous reviews, editorials, and book chapters.
Padda began her tenure at Temple Health and Fox Chase on May 1.